Next Article in Journal
The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma
Next Article in Special Issue
Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer
Previous Article in Journal
Deterioration of Intended Target Volume Radiation Dose Due to Anatomical Changes in Patients with Head-and-Neck Cancer
Previous Article in Special Issue
Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate Cancer
 
 
Review

Article Versions Notes

Cancers 2021, 13(17), 4254; https://doi.org/10.3390/cancers13174254
Action Date Notes Link
article xml file uploaded 24 August 2021 11:55 CEST Original file -
article xml uploaded. 24 August 2021 11:55 CEST Update https://www.mdpi.com/2072-6694/13/17/4254/xml
article pdf uploaded. 24 August 2021 11:55 CEST Version of Record https://www.mdpi.com/2072-6694/13/17/4254/pdf
article html file updated 24 August 2021 11:57 CEST Original file -
article html file updated 28 July 2022 07:31 CEST Update https://www.mdpi.com/2072-6694/13/17/4254/html
Back to TopTop